HER-2 overexpression was also correlated with histological grade with marginal significance: only 14,8% of grade 1–2 carcinomas were HER-2 over expressed compared to 27.5% with grade 3 carcinoma (p = 0.072). This evidence concerns the gene ERBB2 and carcinoma.